Among adults with type 2 diabetes and advanced kidney disease, starting a GLP-1 receptor agonist is linked to a higher rate of serious kidney complications than starting an SGLT2 inhibitor, and this...
Mechanism
Synthesis from 1 study
GLP-1 drugs make the kidneys filter more blood under higher pressure, which hurts already damaged kidneys. This happens more in men and in people without heart failure because their kidneys are still working harder and can't handle the extra strain.
Most probable mechanism
GLP-1 receptor agonists cause the kidneys to filter more blood, which increases pressure inside the filtering units. In people with severely damaged kidneys, this extra pressure damages the filters further. This effect is stronger in men and in people who haven't had heart failure because their kidneys are still trying to work harder, making them more vulnerable to this pressure.
GLP-1 receptor agonists increase glomerular filtration rate by dilating afferent arterioles and constricting efferent arterioles in the kidney
In advanced chronic kidney disease, the glomerular capillary walls are structurally weakened and unable to withstand elevated intraglomerular pressure
Male sex is associated with higher baseline glomerular filtration rate and greater renal vascular reactivity to hormonal stimuli
Absence of pre-existing heart failure is linked to preserved cardiac output and renal perfusion, sustaining elevated glomerular pressure during GLP-1 receptor agonist exposure
Sustained intraglomerular hypertension triggers podocyte injury, glomerulosclerosis, and progressive loss of kidney function
Evidence from Studies
Supporting (1)
Community contributions welcome
Contradicting (0)
Community contributions welcome
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.